R&D Partner Content 5th TCR-based Therapies for Solid Tumors Summit Advancing TCR-based Cell Therapies & Bispecific Approaches
R&D Partner Content Biophysics for Drug Discovery Summit Advance Biophysics Technologies & Applications to Measure Molecular & Target Interactions
R&D Partner Content Polymer Chemistry & Formulation in Drug Delivery Design Your Novel Polymers & Maximize Payload Compatibility for Sustained & Controlled Release
R&D Partner Content 5th Gene Therapy Analytical Development Europe Summit return... Develop, Validate and Implement Analytical Tools for Complex Gene Therapies
R&D Partner Content 7th Gene Therapy for Rare Disorders Summit returns to Boston... Accelerating Safe, Effective & Accessible Therapies in Rare Diseases
R&D Partner Content Viral Vector Process Development & Manufacturing Summit Retu... Enhance Functional Product Quality to Streamline Scale-Up & Reduce COGS
News Repligen builds in cell therapy with $1.5bn BioLife takeover Repligen has reached a deal to buy cell therapy specialist BioLife Solutions for $1.5bn, tapping into a market growing at breakneck speed.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
